BioThrax
Showing 1 - 14 of 14
BioThrax® (Anthrax) Vaccine in Pregnancy Registry
Completed
- Pregnancy Complications
- +2 more
- Observational Intervention
-
San Diego, CaliforniaNaval Health Research Center
Feb 1, 2021
Anthrax Trial in Lenexa (BW-1010: 50 µg - sprayer - IN, BW-1010: 50 µg - pipette - IN, BW-1010: 100 µg - sprayer - IN)
Completed
- Anthrax
- BW-1010: 50 µg - sprayer - IN
- +6 more
-
Lenexa, KansasJohnson County Clin-Trial
May 12, 2022
Anthrax Trial in United States (AV7909 Full Dose (0.5 mL), AV7909 Half Dose (0.25 mL))
Not yet recruiting
- Anthrax
- AV7909 Full Dose (0.5 mL)
- AV7909 Half Dose (0.25 mL)
-
Hickory, North Carolina
- +6 more
Aug 10, 2023
Anthrax Infection Trial in United States (AVA, Ad4-PA-1, Ad4-PA-GPI-1)
Completed
- Anthrax Infection
- AVA
- +2 more
-
Kansas City, Kansas
- +3 more
Mar 3, 2020
Healthy Volunteers Trial in Melbourne, San Antonio (NasoShield, BioThrax, Placebo)
Unknown status
- Healthy Volunteers
- NasoShield
- +2 more
-
Melbourne, Florida
- +1 more
Nov 28, 2018
Bacillus Anthracis (Anthrax) Infection Trial in Miami, Raleigh, Salt Lake City (BioThrax, AV7909 Formulation 1, AV7909
Completed
- Bacillus Anthracis (Anthrax) Infection
- BioThrax
- +5 more
-
Miami, Florida
- +2 more
Aug 1, 2014
Healthy Trial in United States (BioThrax or Anthrax Vaccine Adsorbed)
Completed
- Healthy
- BioThrax or Anthrax Vaccine Adsorbed
-
Birmingham, Alabama
- +4 more
Feb 25, 2014
Anthrax Trial in Baltimore (Recombinant Protective Antigen, Anthrax Vaccine Adsorbed)
Completed
- Anthrax
- Recombinant Protective Antigen, Anthrax Vaccine Adsorbed
-
Baltimore, MarylandUniversity of Maryland School of Medicine
Aug 26, 2010